Connect with others who understand.

sign up log in
Resources
About mySMAteam
Powered By
SMA
NEWS

Scoliosis Surgery in Kids With SMA Can Cause Serious Complications, Research Finds

Posted on January 18, 2022
Medically reviewed by
Evelyn O. Berman, M.D.
Article written by
Emily Wagner, M.S.

  • Corrective surgery for scoliosis in children with spinal muscular atrophy (SMA) type 1 can lead to more serious complications during and after surgery, according to a new study.
  • Four children with SMA type 1 who underwent successful surgery were able to resume receiving nusinersen injections into their spines, but they had serious complications that raised concerns about the procedure.
  • The doctors concluded that the surgery should only be performed after careful consideration and weighing of the risks and benefits.

Nusinersen, sold as Spinraza, is a common treatment for people with SMA — and to work, it needs to be injected directly into a person’s spine. However, it can be difficult to administer in children with kyphoscoliosis, which causes the spine to bend outward and to the side. A recent case series has found that children with SMA type 1 who undergo corrective surgery for severe scoliosis are able to resume Spinraza treatment — but the surgery can also cause significant complications.

Kyphoscoliosis Can Interfere With SMA Treatment

SMA is a neurodegenerative disorder that affects special nerve cells known as motor neurons. These cells are responsible for sending movement signals from the brain to the muscles — in SMA, these are disrupted, making movement difficult.

There are five types of SMA that are divided by their severity. SMA type 1 — also known as Werdnig-Hoffmann disease — is the most common and accounts for 60 percent of cases.

Nusinersen is a specialized medication made of small fragments of genetic material that help fix errors in the survival motor neuron (SMN) genes. Due to its makeup, nusinersen must be injected directly into the spine as an intrathecal injection.

Kyphoscoliosis can make it difficult to administer nusinersen. For this reason, doctors at Children’s Health Ireland performed surgery to correct kyphoscoliosis in four children with SMA type 1.

Share your thoughts with others. Click here to add a comment.

Surgery Leads to Serious Complications

Between July 2020 and June 2021, four children with SMA type 1 — ages 3, 4, 5, and 7 — underwent surgery to correct their kyphoscoliosis. Children with SMA are at a higher risk for complications during surgery compared to those without the disease — including urinary tract infections, infections around the surgical site, and respiratory failure.

Overall, the surgical procedures were successful and all of the children were able to resume their nusinersen injections. This is important because the drug needs to be given every four months for the rest of the childrens’ lives. A recent study, however, found that more than half of people who start Spinraza for SMA stop within two years.

The children in the study also developed more serious complications after the procedure, such as pain and instability, infections, cerebrospinal fluid leaks, and wound opening. Many of these complications required additional surgeries and lengthy hospital stays.

The findings highlight the need for doctors to thoroughly discuss with parents and guardians the benefits and risks of this type of surgery on their children.

“As more children with SMA1 receive nusinersen treatment, more will present for scoliosis correction surgery,” the researchers wrote. “With the risk of a prolonged recovery, surgical, and anesthetic complications, a detailed discussion regarding risks and benefits must be had with the guardian before undertaking such procedures.”

All updates must be accompanied by text or a picture.
Evelyn O. Berman, M.D. is a neurology and pediatric specialist and treats disorders of the brain in children. Review provided by VeriMed Healthcare Network. Learn more about her here.
Emily Wagner, M.S. holds a Master of Science in biomedical sciences with a focus in pharmacology. She is passionate about immunology, cancer biology, and molecular biology. Learn more about her here.

Related articles

About one-third of people with spinal muscular atrophy (SMA) are adults.Adults with SMA may have...

Treatment Options for Adults with SMA

About one-third of people with spinal muscular atrophy (SMA) are adults.Adults with SMA may have...
Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...

Tips for Staying on Spinal Muscular Atrophy (SMA) Therapies

Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...
Spinal muscular atrophy (SMA) is a neuromuscular disorder that causes muscle weakness throughout...

Respiratory Equipment for SMA: What To Look For

Spinal muscular atrophy (SMA) is a neuromuscular disorder that causes muscle weakness throughout...
Until very recently, treatments for spinal muscular atrophy (SMA) could only manage symptoms....

Treatments for Spinal Muscular Atrophy (SMA)

Until very recently, treatments for spinal muscular atrophy (SMA) could only manage symptoms....
Spinal muscular atrophy (SMA) is a genetic, neuromuscular disorder. Because SMA is mostly driven...

Understanding How SMA Gene Therapy Works

Spinal muscular atrophy (SMA) is a genetic, neuromuscular disorder. Because SMA is mostly driven...
Physical therapy can help manage symptoms of SMA like contractures or scoliosis.There are...

Physical Therapy for SMA: How To Get the Most Out of PT

Physical therapy can help manage symptoms of SMA like contractures or scoliosis.There are...

Recent articles

Clinical trials may test new drugs or new dosages or combinations of drugs for spinal muscular...

5 Reasons To Consider Participating in SMA Clinical Trials

Clinical trials may test new drugs or new dosages or combinations of drugs for spinal muscular...
Clinical trials for spinal muscular atrophy (SMA) test new treatments, new dosages of existing...

How Do Clinical Trials Work for SMA?

Clinical trials for spinal muscular atrophy (SMA) test new treatments, new dosages of existing...
Clinical trials are designed with safety as a primary concern.Before a new drug, new dosage, or...

Are Clinical Trials Safe for People With SMA?

Clinical trials are designed with safety as a primary concern.Before a new drug, new dosage, or...
The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. In...

UCSF Health and mySMAteam Partnership: SMA Awareness Month 2022

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. In...
The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...

What People With SMA Should Know About Getting a Second COVID-19 Booster Shot

The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...
Historically, spinal muscular atrophy (SMA) has been difficult to diagnose. The doctors I saw as...

Learning Self-Advocacy at a Young Age: My Experiences

Historically, spinal muscular atrophy (SMA) has been difficult to diagnose. The doctors I saw as...
SMA News
SMA News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close